Skip to main content
. 2017 Mar;9(3):742–756. doi: 10.21037/jtd.2017.03.07

Figure 1.

Figure 1

Kaplan-Meier survival curves stratified by the origin of lesions [primary lung lesions (PLLs) vs. metastatic lung lesions (MLLs)]. (A) Progression-free survival (PFS) for PLLs compared with MLLs; (B) local control (LC) rate for PLLs compared with MLLs; (C) overall survival (OS) in patients with PLLs compared with those with MLLs; (D) survival after the first progression after “stereotactic ablative body radiotherapy” (SABR) in patients with PLLs compared with those with MLLs.